| 1. |
|
|
| 2. |
- Aklint, T, et al.
(författare)
-
Magnetic properties of deposited iron clusters produced in a high-yield laser vaporization source
- 1998
-
Ingår i: APPLIED ORGANOMETALLIC CHEMISTRY. - : JOHN WILEY & SONS LTD. - 0268-2605. ; 12:7, s. 479-484
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Clusters of iron produced in a laser vaporization source have been characterized with time-of-flight spectra and deposited on different substrates for production of films of varying thickness. The magnetic properties of these films with thicknesses of 60
|
|
| 3. |
|
|
| 4. |
- Johannsson, Gudmundur, 1960, et al.
(författare)
-
Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes.
- 1995
-
Ingår i: Arteriosclerosis, thrombosis, and vascular biology. - 1079-5642. ; 15:12, s. 2142-50
-
Tidskriftsartikel (refereegranskat)abstract
- We investigated the influence of gender and apoE and apo(a) phenotypes as well as the effect of the metabolic effects of growth hormone (GH) on the effect of GH therapy on serum lipoprotein concentrations in GH-deficient (GHD) adults. Forty-four consecutive patients, 30 men and 14 women aged 46.5 (range, 19 to 76) years with GHD due mainly to pituitary tumors, were treated with recombinant human GH for 12 months. Serum concentrations of lipoproteins, insulin, thyroxine, and insulin-like growth factor-I were determined, body composition was assessed by bioelectrical impedance, and apo(a) and apoE phenotypes were analyzed. Lipoprotein(a) [Lp(a)] concentrations in the GHD subjects were compared with a gender- and apo(a) phenotype-matched control group. After 12 months of GH treatment, the total cholesterol, LDL cholesterol, and apoB concentrations decreased, the HDL cholesterol and apoE concentrations increased, and the apoA-I and triglyceride concentrations were unchanged. Before treatment, the Lp(a) concentration was similar to that in the control group. However, after 12 months of treatment, the Lp(a) concentration had increased by 44% and 101% above baseline and the control group, respectively. Men and women responded differently to GH, with a more marked increase in Lp(a) concentration and fat-free mass and a more pronounced decrease in body-fat mass in men. Apo(a) phenotypes had no major influence on the effect of GH therapy. The only significant difference between apoE phenotypes was a higher baseline Lp(a) concentration among apoE4 heterozygotes.(ABSTRACT TRUNCATED AT 250 WORDS)
|
|
| 5. |
- Johannsson, Gudmundur, 1960, et al.
(författare)
-
Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults.
- 1997
-
Ingår i: Clinical endocrinology. - 0300-0664. ; 47:5, s. 571-81
-
Tidskriftsartikel (refereegranskat)abstract
- Until now, GH treatment in GH-deficient adults has employed dose schedules of GH based on body weight or body surface area and has ignored individual responsiveness to GH. This trial has studied the effects of an individualized GH dose adjusted to match a combination of clinical response, normalization of serum IGF-I concentration and body composition.Two closely-matched groups, each comprising 30 GH-deficient adults, 38 men and 22 women aged 48 years, were treated with GH for 12 months. The high dose (HD) group received a target dose of 12 micrograms/kg per day and the individualized dose (ID) group received an initial daily GH dose of 0.17 or 0.33 mg per day (0.5 and 1 IU, respectively), independent of body weight, with dose adjustments thereafter.Serum concentrations of IGF-I, lipoprotein(a), insulin, calcium, intact PTH, osteocalcin and blood glucose were measured. Body composition was determined according to a 4-compartment model using total body potassium and tritiated water as input variables. Total body nitrogen was measured by in vivo neutron activation and total body bone mineral content by dual energy X-ray absorptiometry.At 12 months, the daily dose of GH was 0.55 +/- 0.03 mg and 0.45 +/- 0.03 mg in the HD and ID groups, respectively (P < 0.05). In the HD group, the mean serum IGF-I increased to levels well above the predicted level, while in the ID group the mean serum IGF-I normalized. Side-effects were experienced by 70% of the subjects in the HD group and by 30% in the ID group (P < 0.001). A similar response to GH in terms of body composition, glucose homeostasis, lipoprotein(a) and blood pressure was obtained in both treatment groups. However, the treatment response in terms of serum calcium, intact PTH and osteocalcin was more marked in the HD group.Similar efficacy, with a lower dose of GH and fewer side-effects, was obtained by considering individual responsiveness to GH as compared to higher doses of GH adjusted to match body weight.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Kollo, T, et al.
(författare)
-
A unified approach to the approximation of multivariate densities
- 1998
-
Ingår i: SCANDINAVIAN JOURNAL OF STATISTICS. - : BLACKWELL PUBL LTD. ; 25:1, s. 93-109
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Approximation of a density by another density is considered in the case of different dimensionalities of the distributions, The results have been derived by inverting expansions of characteristic functions with the help of matrix techniques, The approxima
|
|
| 9. |
|
|
| 10. |
|
|
